Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2: Renal study
Esmee C.M. Kooijmans1,2, Helena J.H. van der Pal2, Saskia M.F. Pluijm2, Dorine Bresters2,3, Eline van Dulmen-den Broeder1, Margriet van der Heiden-van der Loo2,4, Marry M. van den Heuvel-Eibrink2,5, Leontien C.M. Kremer2, Jacqueline J. Loonen6, Marloes Louwerens7, Sebastian J.C. Neggers8, Maxime Pilon1, Cécile Ronckers2, Wim J.E. Tissing2,9, Andrica C.H. de Vries2,5, Gertjan J.L. Kaspers1,2, Arend Bökenkamp10, Margreet A. Veening1,2
1Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, Amsterdam, the Netherlands
2Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
3Willem Alexander Children's Hospital/Leiden University Medical Center, Leiden, The Netherlands
4Dutch Childhood Oncology Group, Utrecht, the Netherlands
5Department of Pediatric Oncology, Sophia Children's Hospital/Erasmus Medical Center, Rotterdam, the Netherlands
6Department of Hematology, Radboud university medical center, Nijmegen, the Netherlands
7Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
8Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
9Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, the Netherlands
10Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Nephrology, Amsterdam, the Netherlands
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
European Journal of Cancer
Tập 172
287-299
Thông tin tác giả